Charles S. Fuchs, director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital, has been named senior vice president and global head of product development for oncology and hematology at Roche and Genentech.
In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).
